Tam, C. S., Opat, S., D'Sa, S., Jurczak, W., Lee, H., Cull, G., . . . Dimopoulos, M. (2020). A randomized phase 3 trial of zanubrutinib vs ibrutinib in symptomatic Waldenström macroglobulinemia: The ASPEN study. Blood.
Chicago Style citaatTam, Constantine S., et al. "A Randomized Phase 3 Trial of Zanubrutinib Vs Ibrutinib in Symptomatic Waldenström Macroglobulinemia: The ASPEN Study." Blood 2020.
MLA citatieTam, Constantine S., et al. "A Randomized Phase 3 Trial of Zanubrutinib Vs Ibrutinib in Symptomatic Waldenström Macroglobulinemia: The ASPEN Study." Blood 2020.
Let op: Deze citaties zijn niet altijd 100% accuraat.